Thrombosis in patients with myeloproliferative neoplasms. Case report

by Anait L. Melikyan, Irina N. Subortseva, Elena A. Gilyazitdinova, Tamara I. Koloshejnova, Kristina S. Shashkina, Elena K. Egorova, Alla M. Kovrigina, Andrei B. Sudarikov, Lana A. Gorgidze
Published 2021-07-01

The prognostic value of ASXL1 mutation in primary myelofibrosis. Literature review and clinical case description

by A. L. Melikyan, I. N. Subortseva, E. A. Gilyazitdinova, T. I. Koloshejnova, E. K. Egorova, E. I. Pustovaya, A. B. Sudarikov, A. O. Abdullaev, L. A. Gorgidze, D. I. Chebotarev
Published 2020-09-01

Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases

by A L MELIKYAN, I N SUBORTSEVA, E A GILYAZITDINOVA, T I KOLOSHEJNOVA, E I PUSTOVAYA, E K EGOROVA, A M KOVRIGINA, A B SUDARIKOV, A O ABDULLAEV, E G LOMAIA, N T SIORDIYA, A Yu ZARITSKEY, V G SAVCHENKO
Published 2018-07-01